Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...

Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.

The family of an “amazing” mother-of-two who died of an inoperable brain tumour is thanking the hospital which gave her access ...

Lyell Immunopharma, Inc. ( LYEL) TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM EST ...

For Claire Dougherty, every cocktail with friends became an exercise in pain tolerance. The 22-year-old had no idea a ...

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified ...

Genmab’s analyst fair value estimate has been adjusted from DKK 2,182.25 to DKK 2,237.63, while some bullish price targets now cluster in the DKK 2,400 to DKK 2,500 range and around US$40 to US$41.50.

Every child who has completed treatment, every bell which has rung at the end of chemotherapy, has served as evidence that ...

Citius Oncology, Inc. ("Citius Oncology") , an oncology?focused biopharmaceutical company and majority?owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") , today announced positive ...

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...

PARIS, FRANCE, 09 March 2026 ? Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen's decision ...